Documentation for health technology assessment bodies (NICE, SMC) and regulatory bodies (MHRA)

HTAs, STAs, HSTs, and SIPs 

TDPs and ILAP submission documents 

Product/Medical device value dossiers

Global evidence dossiers

Reimbursement dossiers

Discussion guides for stakeholder interviews

Assisting with the identification and communication of appropriate evidence-based product differentiators

Assessment of opportunities and challenges related to the use of a pharmaceutical product or medical device in a given treatment landscape, to optimise market access and uptake

Therapy areas covered include oncology, haematology, rare diseases, neurology and respiratory